HemAware

Featured On HemAware

Why Has Gene Therapy for Hemophilia Been Slow to Catch On?

After years of excitement about a possible “one-and-done” treatment, gene therapy uptake has been slower than expected. Here’s why.
Read More
What Are Biosimilars? A Guide for People with Bleeding Disorders

Similar to biologic medications, this type of therapy is safe and effective and could expand your access to treatment.
Read More
OhmBody: A New Approach to Therapy for Heavy Menstrual Bleeding

The wearable wellness device works without medications or hormones and complements other bleeding disorder treatments.
Read More

OhmBody: A New Approach to Therapy for Heavy Menstrual Bleeding

In a rapidly changing hemophilia treatment landscape, shared decision-making helps patients and providers choose the option that fits best.

Taking Charge, Hemophilia A&B

It took years for Julie Schiffmacher to be diagnosed with von Willebrand disease. Now she’s turning that experience into advocacy.

My Journey

These two bleeding disorders share some similarities but are also unique in significant ways. Here’s what you need to know.

Hemophilia A&B, Von Willebrand Disease

Menstruation tracking is a valuable tool. Experts say to be vigilant in what information you share.

Women's Bleeding Disorders, Taking Charge

The rare condition usually affects people in their 70s and 80s without warning. Here’s what you need to know.

Adults & Aging, Rare Bleeding Disorders

Heavy periods with a bleeding disorder are common, and there are safe, private options to help teens manage them.

This rebalancing agent can help people with hemophilia A or B — with or without inhibitors — to better control...

Hemophilia A&B, Novel Technologies

Need Information about Bleeding Disorders?

Contact The Neil Frick Resource Center (NFRC)